The approval further expands OVOLUX's global regulatory standing and provides brand owners with additional opportunities to support skin health in the Canadian market.
Under the newly issued product license, OVOLUX is authorised for claims including helping to improve skin hydration, elasticity, and firmness, while also supporting overall skin health. Health Canada also approved claims related to improving and supporting skin hydration and elasticity, reinforcing the ingredient's versatility for beauty-focused formulations.
Health Canada's authorisation of these claims represents another important milestone for OVOLUX and validates the growing body of science supporting eggshell membrane as a unique beauty-from-within ingredient,
Said Arun Nair, Chief Commercial Officer of Stratum Nutrition.
As consumer demand for clinically supported skin health solutions continues to grow, OVOLUX offers brands an innovative, sustainable ingredient that addresses key aspects of skin appearance and health.
Derived from eggshell membrane, OVOLUX is an ultra-low dose eggshell membrane ingredient that naturally contains collagen types I, V, and X along with other bioactive compounds that support skin wellness. The Health Canada approval strengthens Stratum Nutrition's commitment to delivering science-backed ingredients that meet the evolving needs of consumers and product developers worldwide.
Health Canada OVOLUX Approved Claims:
- Helps to improve skin hydration.
- Helps to improve skin elasticity.
- Helps to increase skin firmness.
- Helps to support skin health.
- Improves and supports skin hydration and elasticity.
- Helps to improve and support skin hydration and elasticity.
- Helps increase skin elasticity.
- Helps augment skin elasticity.
